US 6518061
IL-13 receptor specific chimeric proteins and uses thereof
expired A61KA61K2039/505A61K38/00
Quick answer
US patent 6518061 (IL-13 receptor specific chimeric proteins and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K47/642, A61K47/6849